within Pharmacolibrary.Drugs.ATC.A;

model A02BD17
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.85,
    Cl             = 0.175,
    adminDuration  = 600,
    adminMass      = 0.02,
    adminCount     = 1,
    Vd             = 0.18,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.018333333333333333,
    Tlag           = 600
  );

  annotation(Documentation(
    info ="<html><body><p>Vonoprazan and amoxicillin is a combination therapy used mainly for the eradication of Helicobacter pylori infection. Vonoprazan is a potassium-competitive acid blocker (P-CAB) that inhibits gastric acid secretion, while amoxicillin is a broad-spectrum beta-lactam antibiotic. This combination is clinically approved and used, particularly in Asia, for H. pylori eradication regimens as an alternative to traditional proton pump inhibitor-based therapies.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters are estimated based on monotherapy data for vonoprazan and amoxicillin in healthy adult subjects, due to lack of published combined PK model data for fixed-dose or co-administered combination.</p><h4>References</h4><ol><li>Hirotoshi Echizen,The First-in-Class Potassium-Competitive Acid Blocker, Vonoprazan Fumarate: Pharmacokinetic and Pharmacodynamic Considerations.,Clinical pharmacokinetics,2016<a href='https://pubmed.ncbi.nlm.nih.gov/26369775/'>https://pubmed.ncbi.nlm.nih.gov/26369775/</a></li><li>Yuuichi Sakurai, Madoka Shiino, Hiroyuki Okamoto, Akira Nishimura, Koki Nakamura, Setsuo Hasegawa,Pharmacokinetics and Safety of Triple Therapy with Vonoprazan, Amoxicillin, and Clarithromycin or Metronidazole: A Phase 1, Open-Label, Randomized, Crossover Study.,Advances in therapy,2016<a href='https://pubmed.ncbi.nlm.nih.gov/27432383/'>https://pubmed.ncbi.nlm.nih.gov/27432383/</a></li></ol></body></html>",
    revisions = "<html><body><ul><li>06/2025 model generated by LLM gpt-4.1, references by scholarly and scripts created by Tomas Kulhanek</li></ul></body></html>"
  ));
end A02BD17;
